Видео с ютуба Novartis Ag

25 Years of Novartis – Continuing our innovation journey

Corporate responsibility at Novartis

Novartis AG - Annual Press Conference 2017

James Surowiecki talks with CEO of Novartis AG Dan Vasella - Conversations - The New Yorker

The Story of Life and Leadership of Shreeram Aradhye | Chief Medical Officer of Novartis

Novartis Cancer Drug Is Approved With $475,000 Price Tag

Novartis — история и профиль компании (обзор)

AMP HF Industry Partners - Novartis AG

i Novartis Неванак 1мг Краплі очні Катаракта Nevanac 1mg Eye Drops Cataract Неванок Катаракта 202411

Часть 3: Анализ крупнейших фармацевтических компаний:Novartis AG (NOVN) и Bayer AG.

India's Supreme Court rejects Novartis AG's right to patent new version of cancer drug

Суд между Novartis и FDA. #fda #novartis #суд #news #новости #медицинскиеновости #medicalnews

Novartis Access – measuring the impact

Novartis Research & Development

Novartis AG - Annual Press Conference 2011 CEO Joseph Jimenez - earnings report

Novartis-CEO: Auslaufende Patente vorübergehende Herausforderung

Accelerate Action to close the global gender health gap

Speeches - Annual Press Conference 2014 Novartis AG

Novartis Life